Atlas Venture
http://www.atlasventure.com/Atlas Venture is a venture capital firm that invests in early stage technology and life sciences businesses. Since the firm’s founding in 1980, the firm has helped build over three hundred companies. Since 1995, forty seven of its investments have been acquired and more than forty have gone public, with an aggregate market capitalization of over $20 billion.
View Older Stories View More Recent Stories
-
Padlock Therapeutics Appoints Adelene Perkins to Board of Directors
-
Luc Therapeutics Announces License and Collaboration Agreement to Accelerate Development of Its Program for the Treatment of Depression
-
SoapBox Secures $3M to Power "The High Performance Workforce"
-
SoapBox Secures $3M to Power "The High Performance Workforce"
-
OYO Sports Names Scott Healy new President and Chief Executive Officer
-
Navitor Pharmaceuticals’ Scientific Founder Makes Landmark Discovery of the Molecular Sensor for the Amino Acid Leucine
-
Quartet Medicine Completes $23.25 Million Series A Financing
-
Rodin Therapeutics Appoints Adam J. Rosenberg as Chief Executive Officer
-
Padlock Therapeutics Named by FierceBiotech as a 2015 “Fierce 15” Biotech Company
-
Replimune Ltd Raises $30 Million Series A Financing
-
Synlogic Accelerates Business Growth with Appointment of President, Expansion of Financing, and an Industry Collaboration
-
Best of Boston biotech startups win recognition at BioPharm America™ 2015 during Johnson & Johnson Innovation Startup Day competition
-
EBD Group to announce the Johnson & Johnson Innovation Startup Day competition grand prize winner at BioPharm America™ 2015 Partnering Event
-
Appcito Introduces Application Delivery Services for VMware-Based Enterprise Clouds
-
Navitor Pharmaceuticals Appoints David M. Madden to Board of Directors and Michael N. Hall, PhD, to Scientific Advisory Board
-
Intellia Therapeutics Secures $70 Million in Series B Financing
-
Mobee Closes $5M Series A Financing
-
AppInside Funded to Secure Mobile Apps and Protect Their Users
-
Skillz Showcases Live Events Platform At Casual Connect USA
-
JenaValve Receives $26.5 Million Financing
-
JenaValve Appoints Peter C. Wulff as Chief Financial Officer
-
Integral Ad Science Raises $67 Million to Fund Advancements in Technology and Further Global Expansion
-
LTG Exam Receives Additional Strategic Investment for Seed Funding, Brings Total to $3.6 Million
-
DraftKings Secures $300MM In Funding From All-Star Lineup
-
RaNA Therapeutics Secures $55 Million in Oversubscribed Series B Financing
-
LexShares Extends Litigation Funding Opportunities to Institutional Investors
-
Appcito Introduces Application Delivery Solution For Microsoft Azure Cloud
-
Skillz Introduces Live Events Platform Allowing Anyone to Organize and Host eSports Competitions
-
Influitive Raises $30.5M in Series B Round
-
ITeos Therapeutics Announces Appointment of Dr. Bruno Montanari to the Company's Board of Directors
-
Quartet Medicine Announces Neuron Publication Validating Role of the BH4 Pathway in Chronic Neuropathic and Inflammatory Pain
-
Navitor Pharmaceuticals Appoints Paul Friedman, MD, to Its Board of Directors
-
Synlogic to Present at Several Upcoming Scientific and Industry Conferences
-
Unum Therapeutics Announces $65 Million Series B Financing Round
-
Spero Completes $30 Million Financing
-
Skillz Pays Out $10 Million in eSports Prizes
-
JenaValve Appoints Victoria E. Carr-Brendel, Ph.D., as Chief Executive Officer
-
Threat Stack Names Brian M. Ahern as New Chairman & CEO
-
Padlock Therapeutics Accelerates Pipeline Development Through Agreement with GSK
-
Raze Therapeutics Announces Addition of Robert Copeland, PhD, to Scientific Advisory Board
-
Jose-Carlos Gutiérrez-Ramos, Ph.D. Joins Synlogic as Chief Executive Officer
-
Quartet Medicine Announces Scientific Advisory Board Comprising Academic and Industry Neuroscience Leaders
-
Skillz Brings Live Streaming and Instant Replays to Mobile eSports
-
Critical Outcome Technologies Strengthens Its Board
-
Surface Oncology Appoints Detlev Biniszkiewicz as Chief Executive Officer
-
Padlock Therapeutics Assembles Scientific Advisory Board with World Leaders in PAD Enzyme Biology and Autoimmune Disease
-
Intellia Therapeutics Announces Dr. Jennifer Doudna and Dr. Derrick Rossi to Join Company
-
Intellia Therapeutics Announces the Appointment of Dr. Sapna Srivastava as Chief Finance & Strategy Officer
-
Founders Share Exchange Committed to Founders of Pre-Seed Stage Startups
-
InsureMyTrip and Hopper Research show spike in travel to Europe this summer

